Literature DB >> 27373880

Transferrin receptor 1: a target for antibody-mediated cancer therapy.

Tracy R Daniels-Wells1, Manuel L Penichet1,2,3,4,5.   

Abstract

Entities:  

Keywords:  CD71; antibody effector functions; cancer immunotherapy; cytotoxic antibody; drug delivery; iron deprivation; receptor-mediated endocytosis; transferrin receptor 1

Mesh：

Substances：

Year:  2016        PMID： 27373880     DOI： 10.2217/imt-2016-0050

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  16 in total

1.  Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma.

Authors:  Lai Sum Leoh; Yoon Kyung Kim; Pierre V Candelaria; Otoniel Martínez-Maza; Tracy R Daniels-Wells; Manuel L Penichet
Journal:  J Immunol       Date:  2018-04-13       Impact factor: 5.422

Review 2.  Iron and Cancer: 2020 Vision.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Cancer Res       Date:  2020-09-14       Impact factor: 12.701

3.  An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication.

Authors:  Tracy R Daniels-Wells; Pierre V Candelaria; Lai Sum Leoh; Miguel Nava; Otoniel Martínez-Maza; Manuel L Penichet
Journal:  J Immunother       Date:  2020 Feb/Mar       Impact factor: 4.912

Review 4.  Iron: The cancer connection.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Mol Aspects Med       Date:  2020-04-25

5.  Blocking transferrin receptor inhibits the growth of lung adenocarcinoma cells in vitro.

Authors:  Yihe Wu; Jinming Xu; Jinbo Chen; Meirong Zou; Aizemaiti Rusidanmu; Rong Yang
Journal:  Thorac Cancer       Date:  2017-12-29       Impact factor: 3.500

6.  MiR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1.

Authors:  Yuxiang Fu; Liewen Lin; Ligang Xia
Journal:  Cell Mol Biol Lett       Date:  2019-05-16       Impact factor: 5.787

7.  Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary B-cells.

Authors:  Laura E Martínez; Tracy R Daniels-Wells; Yu Guo; Larry I Magpantay; Pierre V Candelaria; Manuel L Penichet; Otoniel Martínez-Maza; Marta Epeldegui
Journal:  Mol Cancer Ther       Date:  2021-06-22       Impact factor: 6.261

Review 8.  Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?

Authors:  Christopher Montemagno; Shamir Cassim; Nicolas De Leiris; Jérôme Durivault; Marc Faraggi; Gilles Pagès
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

9.  Expression of transferrin receptor-1 (TFR-1) in canine osteosarcomas.

Authors:  Gionata De Vico; Manuela Martano; Paola Maiolino; Francesca Carella; Leonardo Leonardi
Journal:  Vet Med Sci       Date:  2020-04-02

Review 10.  Translational molecular imaging in exocrine pancreatic cancer.

Authors:  Bart Cornelissen; James C Knight; Somnath Mukherjee; Laura Evangelista; Catarina Xavier; Federico Caobelli; Silvana Del Vecchio; Latifa Rbah-Vidal; Jacques Barbet; Marion de Jong; Fijs W B van Leeuwen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-17       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.